Trial NCT00042952

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02481
Secondary IDs: CDR0000069487 CLB-90105 U10CA031946

Last trial update was posted on 2013-01-17

MeSH Interventions

Imatinib Mesylate

MeSH Conditions

Dysgerminoma Germinoma Neoplasms, Germ Cell and Embryonal Ovarian Neoplasms Recurrence Seminoma Testicular Neoplasms

Other Conditions

Ovarian Dysgerminoma Recurrent Malignant Testicular Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor Stage II Malignant Testicular Germ Cell Tumor Stage II Ovarian Germ Cell Tumor Stage III Malignant Testicular Germ Cell Tumor Stage III Ovarian Germ Cell Tumor Testicular Seminoma

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID